AB0658 FEAR OF COVID-19 IN POSTPARTUM WOMEN WITH RHEUMATIC DISEASE
Authors: L. G. Espinosa Banuelos, M. E. Corral Trujillo, C. M. Skinner Taylor, L. Pérez Barbosa, R. A. Rodriguez Chavez, A. Y. Lujano Negrete, R. Moyeda Martinez, A. Cárdenas, D. Á. Galarza-Delgado
Journal: Annals of the Rheumatic Diseases (2021)

Background: In Mexico, the SARS-CoV-2 pandemic has totaled almost two million cases and exceeded 150,000 deaths (29/01/2021). Currently, COVID-19 has become the leading cause of death in pregnant women in Mexico. COVID-19 has additionally impacted the psychological health of individuals including women with rheumatic diseases. Objectives: The aim of this study is to compare the Fear of COVID-19 Scale (FCV-19S) in postpartum women with and without autoimmune rheumatic diseases. Methods: A cross-sectional, descriptive, and comparative study was conducted. The Spanish FCV-19S version was applied by telephone or e-mail. The instrument consists of seven items, each with a five-point Likert scale of options. The participant must choose the options that best represent their perception about the statements presented. The maximum possible total is 35 points. Sociodemographic information was collected from the clinical charts. The Kolmogorov-Smirnov test was used to determine normality of the data. Statistical analysis was done using the Mann-Whitney U test. Results: Forty-four postpartum women were included (22 from the Pregnancy and Rheumatic Diseases Clinic and 22 from the Obstetrics Department, both groups from the University Hospital “Dr. José E. González in Monterrey, México). The mean level of fear found in women with rheumatic disease was 16 (6.6) points versus 14 (4.6) points in the non-rheumatic patients group. No significant difference was found between groups (p=0.65). Regarding the rheumatic diseases group, women in the category of other diagnoses (that included Sjögren’s Syndrome, antiphospholipid syndrome, and dermatomyositis) had a greater mean FCV-19S score (20.2), than patients with systemic lupus erythematosus (17.3) and rheumatoid arthritis (15.4). Conclusion: Women with postpartum rheumatic disease had a higher FCV-19S score than postpartum women without rheumatic diseases, although this difference was not statistically significant. References: [1]Lumbreras-Marquez MI, Campos-Zamora M, Seifert SM, et al. Excess Maternal Deaths Associated With Coronavirus Disease 2019 (COVID-19) in Mexico. Obstet Gynecol. 2020;136(6):1114-1116. doi:10.1097/AOG.0000000000004140 [2]Yan H, Ding Y, Guo W. Mental Health of Pregnant and Postpartum Women During the Coronavirus Disease 2019 Pandemic: A Systematic Review and Meta-Analysis. Front Psychol. 2020;11:617001. Published 2020 Nov 25. doi:10.3389/fpsyg.2020.617001 Table 1. Sociodemographic data Women with rheumatic diseases N= 22 Women without rheumatic diseases N= 22 p= Age, years, mean, (SD ) 28 (6.8) 23 (5.0) 0.65 Occupation, n (% ) Housewive 14 (63.6) 18 (81.8) Employee 5 (22.7) 3 (13.6) Other 3 (13.6) 1 (4.5) Education level, n (% ) 0.28 Middle school 10 (45.45) 16 (72.72) High School 8 (36.36) 5 (22.72) College 4 (18.18) 1 (4.54) Rheumatic diagnosis, n(% ) Rheumatoid arthritis 9 (40.9) Systemic lupus erythematosus 8 (36.6) Others (SS, APS, DM) 5 (22.7) SS: Sjögren’s syndrome, APS: antiphospholipid syndrome, DM: dermatomyositis Disclosure of Interests: None declared.